Steroid resistant nephrotic syndrome: Recent developments

Indian Pediatrics

Volumn 43, Issue 1, 2006, Pages 9-13

  Bagga, Arvind ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; VINCRISTINE;

ANTIGEN PRESENTATION; ATOPY; BODY HEIGHT; BONE DENSITY; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG SUBSTITUTION; EDITORIAL; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE DISTURBANCE; GENE MUTATION; GONAD DYSFUNCTION; GROWTH DISORDER; HOSPITALIZATION; HUMAN; HYPERPLASIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOADSORPTION; INFECTION; LONG TERM CARE; MONOTHERAPY; NEPHROTIC SYNDROME; NEPHROTOXICITY; PATHOGENESIS; PLASMAPHERESIS; PODOCYTE; PROTEINURIA; REMISSION; SIDE EFFECT; T LYMPHOCYTE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

DISEASE PROGRESSION; DRUG RESISTANCE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; NEPHROTIC SYNDROME; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STEROIDS; SURVIVAL RATE;

EID: 32644451375     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res 2005; 122: 13-28.
2. Kitiyakara C, Kopp JB, Eggers P. Trends in epidemiology of focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: 172-182.
3. Kim JS, Bellew CA, Silverstein DM, Aviles DH, Boineau FG, Vehaskari VM. High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kidney Int 2005; 68: 1275-1281.
4. Mathieson PW. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant. 2003; 18 (suppl): 26-29.
5. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999; 10: 529-537.
6. Szeto C, Gillespie KM, Mathieson PW. Levamisole induces interleukin-18 and shifts type1/type2 cytokine balance. Immunology 2000; 100: 217-224.
7. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001; 59: 2126-2133.
8. Antignac C. Molecular basis of steroid-resistant nephrotic syndrome. Nefrologia 2005; 25 (suppl): 25-28.
9. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004; 15: 722-732.
10. Moudgil A, Bagga A, Jordan SC. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. Pediatr Nephrol 2005; 20: 1376-1381.
11. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 1995; 43: 84-88.
12. Hari P, Bagga A, Jindal N, Srivastava RN. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol 2001; 16: 901-905.
13. Hari P, Bagga A, Mantan M. Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome. Indian Pediatr 2004; 41: 993-1000.
14. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report for the International Study of Kidney Disease in Children. Pediatr Nephrol 1996; 10: 590-593.
15. Gulati S, Kher V. Intravenous pulse cyclophosphamide-A new regime for steroid resistant focal segmental glomerulosclerosis. Indian Pediatr 2000; 37: 141-148.
16. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediatr Nephrol 2003; 18: 351-356.
17. Mantan M, Bagga A, Sriram CS, Hari P. Efficacy of IV pulse cyclophosphamide versus IV pulse steroids and oral cyclophosphamide for steroid resistant nephrotic syndrome. Pediatr Nephrol 2004; 19: C73.
18. Cattran DC, Appel GB. Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, et al. for the North America Nephrotic Syndrome Study Group. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 1999; 56: 2220-2226.
19. Habashi D, Hodson E, Craig J. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane database system review 2004; 2: CD 003594
20. Ijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 2002; 61: 1801-1805.
21. Ulinski T, Duborg L, Said MH, Parchoux B, Ranchin B, Cochat P. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr Nephrol 2005; 20: 482-485.
22. Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB. Use of mycophenolate mofetil in steroid-dependent and steroid-resistant nephrotic syndrome Pediatr Nephrol 2003; 18: 833-837.
23. Gulati S, Sengupta D, Sharma RK, Sharma A, Gupta RK, Singh U, et al. Steroid resistant nephrotic syndrome. Indian Pediatr 2006; 43: 55-60.
24. Nammalwar BR, Vijayakumar M, Prahlad N, Jain DV. Steroid resistant nephrotic syndrome: Is sustained remission attainable? Indian Pediatr 2006; 43: 39-43.
25. Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K. Cyclosporine in steroid dependent and resistant nephrotic syndrome. Indian Pediatr 2006; 43: 14-19.
26. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, et al. Membranoproliferative glomerulonephritis: an update. J Am Soc Nephrol 2005; 16: 1392-1403.
27. Loeffler K, Gowrishankar M, Yiu V. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome. Pediatr Nephrol 2004; 19: 281-287.